Drug Side Effects

ESOMEPRAZOLE MAGNESIUM DIHYDRATE

ESOMEPRAZOLE MAGNESIUM DIHYDRATE was reported 14491 times

ESOMEPRAZOLE MAGNESIUM DIHYDRATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 SYNOVIAL FLUID ANALYSIS 25 0.2907
1 HAEMORRHAGE FOETAL 15 0.2830
2 NEUROLOGIC NEGLECT SYNDROME 151 0.2731
3 EJECTION FRACTION 137 0.2374
4 SENSITISATION 176 0.2325
5 BRONCHIAL NEOPLASM 27 0.2000
6 CAROTID ARTERY THROMBOSIS 152 0.1803
7 CARDIOSPASM 89 0.1615
8 FOETAL ANAEMIA 18 0.1385
9 IMMUNISATION 54 0.1262
10 NIPPLE SWELLING 31 0.1235
11 PALMOPLANTAR KERATODERMA 86 0.1210
12 POST CHOLECYSTECTOMY SYNDROME 33 0.1187
13 HEPATOJUGULAR REFLUX 19 0.1145
14 ADJUSTMENT DISORDER 147 0.1141
15 POLYCYSTIC OVARIES 175 0.1128
16 BRONCHIAL HAEMORRHAGE 27 0.0868
17 SYSTEMIC LUPUS ERYTHEMATOSUS RASH 67 0.0846
18 GRANULOCYTE COUNT INCREASED 33 0.0825
19 ELECTROCARDIOGRAM Q WAVE ABNORMAL 18 0.0786
20 JAW CLICKING 15 0.0761
21 VIRAL TEST POSITIVE 27 0.0746
22 ENDOMETRIAL ABLATION 26 0.0743
23 HUMAN RHINOVIRUS TEST POSITIVE 27 0.0734
24 NASAL TURBINATE HYPERTROPHY 27 0.0728
25 TENOSYNOVITIS STENOSANS 38 0.0688
26 PNEUMONIA HAEMOPHILUS 33 0.0688
27 PERSONALITY DISORDER 158 0.0607
28 BLOOD IMMUNOGLOBULIN A INCREASED 32 0.0605
29 ASPARTATE AMINOTRANSFERASE 14 0.0583
30 EJECTION FRACTION ABNORMAL 70 0.0578
31 NEPHRITIC SYNDROME 16 0.0525
32 BUNION OPERATION 29 0.0523
33 SYNOVIAL DISORDER 23 0.0512
34 CEREBRAL ARTERY THROMBOSIS 26 0.0508
35 ELECTRIC SHOCK 42 0.0502
36 RHEUMATOID NODULE 136 0.0495
37 BRAIN SCAN ABNORMAL 27 0.0487
38 GRANULOMA SKIN 36 0.0440
39 GLOMERULAR FILTRATION RATE INCREASED 35 0.0436
40 OBSTRUCTIVE SLEEP APNOEA SYNDROME 60 0.0435
41 ATRIAL TACHYCARDIA 90 0.0432
42 RHINITIS ALLERGIC 189 0.0431
43 VITAMIN B12 INCREASED 33 0.0423
44 RESPIRATORY SYNCYTIAL VIRUS TEST POSITIVE 29 0.0417
45 PHYSICAL DECONDITIONING 95 0.0384
46 PRURITUS GENITAL 88 0.0383
47 DACTYLITIS 35 0.0361
48 MULTI-ORGAN DISORDER 68 0.0347
49 NEPHRECTOMY 49 0.0334
50 PRODUCT USED FOR UNKNOWN INDICATION 41 0.0333
51 OCCULT BLOOD 17 0.0323
52 RHEUMATOID FACTOR INCREASED 32 0.0290
53 PANCREATIC NEUROENDOCRINE TUMOUR 17 0.0269
54 BLOOD PARATHYROID HORMONE DECREASED 38 0.0258
55 CAROTID ARTERY OCCLUSION 93 0.0257
56 ALLERGY TO CHEMICALS 31 0.0252
57 INTERVERTEBRAL DISCITIS 45 0.0241
58 CAROTID ARTERIOSCLEROSIS 24 0.0237
59 HEMIPLEGIA 188 0.0228
60 NASAL DISCHARGE DISCOLOURATION 31 0.0227
61 HYPERTENSIVE NEPHROPATHY 24 0.0225
62 SCLERITIS 34 0.0216
63 SLEEP TERROR 89 0.0214
64 MAST CELL ACTIVATION SYNDROME 28 0.0214
65 TENSION HEADACHE 88 0.0207
66 ASPARTATE AMINOTRANSFERASE ABNORMAL 30 0.0201
67 URINE LEUKOCYTE ESTERASE POSITIVE 14 0.0200
68 SENSORY LOSS 159 0.0199
69 RHONCHI 27 0.0198
70 DENTAL RESTORATION FAILURE 14 0.0197
71 BRONCHIAL DISORDER 30 0.0195
72 HEPATITIS VIRAL 15 0.0190
73 SYSTOLIC DYSFUNCTION 19 0.0183
74 PANNICULITIS 42 0.0176
75 JOINT NOISE 33 0.0172
76 GANGRENE 103 0.0172
77 AFFECT LABILITY 160 0.0168
78 SYNOVIAL CYST 75 0.0164
79 WHITE BLOOD CELLS URINE POSITIVE 30 0.0163
80 MOTOR DYSFUNCTION 161 0.0161
81 CREPITATIONS 46 0.0155
82 HELICOBACTER GASTRITIS 19 0.0154
83 BLOOD TEST ABNORMAL 213 0.0154
84 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 16 0.0151
85 NIPPLE PAIN 30 0.0149
86 BREATH SOUNDS ABNORMAL 71 0.0146
87 COORDINATION ABNORMAL 198 0.0143
88 DIABETIC NEPHROPATHY 31 0.0142
89 DRUG TOLERANCE DECREASED 39 0.0141
90 MAJOR DEPRESSION 101 0.0140
91 SLEEP APNOEA SYNDROME 259 0.0137
92 TONGUE BITING 28 0.0137
93 CATARRH 12 0.0137
94 CARPAL TUNNEL SYNDROME 187 0.0135
95 ARTERIAL OCCLUSIVE DISEASE 104 0.0133
96 MUSCLE SPASTICITY 163 0.0133
97 PLEURITIC PAIN 36 0.0132
98 AREFLEXIA 34 0.0128
99 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 204 0.0128
100 RESPIRATORY TRACT CONGESTION 198 0.0126
101 ANAEMIA MACROCYTIC 25 0.0120
102 NEPHROSCLEROSIS 13 0.0118
103 NEPHROPATHY 106 0.0114
104 CHRONIC KIDNEY DISEASE 861 0.0114
105 RENAL ATROPHY 14 0.0113
106 DEMYELINATION 46 0.0113
107 FIBROMYALGIA 271 0.0113
108 HAEMATOMA MUSCLE 13 0.0112
109 SINUS CONGESTION 149 0.0112
110 CUSHINGOID 35 0.0110
111 END STAGE RENAL DISEASE 198 0.0109
112 FACIAL PAIN 95 0.0108
113 GASTRIC POLYPS 24 0.0107
114 BLOOD PRESSURE DIASTOLIC DECREASED 75 0.0103
115 DIASTOLIC DYSFUNCTION 31 0.0101
116 VITAMIN B12 DEFICIENCY 39 0.0098
117 RED BLOOD CELL SEDIMENTATION RATE INCREASED 107 0.0098
118 HEMIPARESIS 163 0.0097
119 ENTHESOPATHY 15 0.0096
120 CARDIAC DISCOMFORT 19 0.0096
121 MONOCYTE COUNT INCREASED 34 0.0095
122 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 13 0.0094
123 ESSENTIAL HYPERTENSION 24 0.0094
124 SUBARACHNOID HAEMORRHAGE 94 0.0093
125 VASCULITIS 106 0.0092
126 FULL BLOOD COUNT ABNORMAL 95 0.0091
127 MALNUTRITION 100 0.0091
128 ANTINUCLEAR ANTIBODY POSITIVE 29 0.0090
129 THROAT CLEARING 33 0.0090
130 SKIN HAEMORRHAGE 126 0.0088
131 SEDATION 224 0.0087
132 NEPHROGENIC ANAEMIA 40 0.0087
133 PSEUDOMONAL SEPSIS 15 0.0086
134 EPIGASTRIC DISCOMFORT 33 0.0085
135 VENTRICULAR HYPOKINESIA 27 0.0085
136 ULCER 133 0.0085
137 HYPOTHYROIDISM 252 0.0080
138 GRANULOMA 27 0.0079
139 EATING DISORDER 166 0.0079
140 BLOOD PRESSURE SYSTOLIC DECREASED 35 0.0078
141 INGROWING NAIL 18 0.0077
142 FOOT DEFORMITY 84 0.0077
143 TENDERNESS 79 0.0077
144 LOSS OF EMPLOYMENT 23 0.0077
145 CHRONIC SINUSITIS 28 0.0076
146 POST-TRAUMATIC STRESS DISORDER 50 0.0075
147 BURNS SECOND DEGREE 13 0.0075
148 VENTRICULAR TACHYCARDIA 123 0.0075
149 RENAL INJURY 221 0.0075
150 NIGHTMARE 253 0.0074
151 CHOLECYSTITIS ACUTE 41 0.0073
152 CYTOLYTIC HEPATITIS 24 0.0072
153 SKIN NECROSIS 37 0.0072
154 JOINT EFFUSION 49 0.0072
155 PERICARDITIS 117 0.0071
156 BLOOD PRESSURE DIASTOLIC ABNORMAL 18 0.0071
157 NERVE INJURY 78 0.0071
158 SINUS DISORDER 137 0.0070
159 REBOUND ACID HYPERSECRETION 21 0.0069
160 CAROTID ARTERY STENOSIS 24 0.0069
161 SEROTONIN SYNDROME 130 0.0069
162 NEPHROLITHIASIS 310 0.0069
163 LEFT VENTRICULAR HYPERTROPHY 29 0.0069
164 RHEUMATOID FACTOR POSITIVE 39 0.0068
165 LUNG OPACITY 17 0.0067
166 BLOOD URIC ACID INCREASED 38 0.0067
167 DYSPNOEA AT REST 19 0.0066
168 SNEEZING 146 0.0066
169 TUBULOINTERSTITIAL NEPHRITIS 121 0.0065
170 BLOOD PRESSURE SYSTOLIC ABNORMAL 16 0.0065
171 ANAL ABSCESS 34 0.0064
172 OBSTRUCTIVE AIRWAYS DISORDER 70 0.0064
173 PULMONARY CONGESTION 83 0.0064
174 TOOTH INFECTION 82 0.0063
175 RHINITIS 50 0.0063
176 GASTROOESOPHAGEAL REFLUX DISEASE 489 0.0062
177 ANOSMIA 88 0.0061
178 HYPERPARATHYROIDISM SECONDARY 15 0.0060
179 MUSCLE CONTRACTIONS INVOLUNTARY 21 0.0060
180 LARGE INTESTINE POLYP 41 0.0060
181 MYCOBACTERIUM TUBERCULOSIS COMPLEX TEST POSITIVE 14 0.0060
182 APHASIA 179 0.0060
183 CATHETER SITE PAIN 15 0.0060
184 PHLEBITIS 30 0.0059
185 ANGIOEDEMA 254 0.0058
186 BLOOD IMMUNOGLOBULIN E INCREASED 14 0.0058
187 DYSLIPIDAEMIA 29 0.0058
188 PULMONARY TOXICITY 40 0.0058
189 FOOT OPERATION 28 0.0058
190 EYE HAEMORRHAGE 76 0.0058
191 ATELECTASIS 55 0.0057
192 MIOSIS 45 0.0057
193 POLYP 37 0.0057
194 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 36 0.0057
195 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 46 0.0056
196 DRUG DELIVERY SYSTEM MALFUNCTION 28 0.0056
197 INJECTION SITE HYPERSENSITIVITY 17 0.0056
198 RHINALGIA 15 0.0056
199 KIDNEY INFECTION 107 0.0055
200 INFUSION SITE PRURITUS 17 0.0055
201 HEPATOSPLENOMEGALY 14 0.0055
202 TEMPERATURE INTOLERANCE 55 0.0055
203 THYROID DISORDER 83 0.0055
204 HEPATIC PAIN 23 0.0054
205 RALES 31 0.0054
206 SWOLLEN TONGUE 164 0.0053
207 CYSTITIS 166 0.0053
208 HYPOMAGNESAEMIA 72 0.0053
209 C-REACTIVE PROTEIN INCREASED 187 0.0052
210 ADRENAL INSUFFICIENCY 61 0.0052
211 CONTRAINDICATED PRODUCT ADMINISTERED 153 0.0051
212 NEUTROPHIL COUNT INCREASED 52 0.0051
213 VITAMIN D DEFICIENCY 49 0.0051
214 RENAL CYST 40 0.0051
215 DIPLOPIA 130 0.0051
216 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 237 0.0051
217 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 352 0.0050
218 AORTIC VALVE INCOMPETENCE 21 0.0050
219 RENAL DISORDER 230 0.0050
220 PRE-EXISTING CONDITION IMPROVED 31 0.0050
221 ARTHRITIS 387 0.0050
222 HUNGER 66 0.0050
223 GASTROINTESTINAL MOTILITY DISORDER 26 0.0050
224 ANGINA PECTORIS 141 0.0050
225 ACUTE KIDNEY INJURY 740 0.0049
226 WHEEZING 285 0.0049
227 PERICARDIAL EFFUSION 110 0.0048
228 MOUTH HAEMORRHAGE 35 0.0048
229 BLOOD IRON DECREASED 55 0.0047
230 DYSARTHRIA 175 0.0047
231 BURSITIS 56 0.0047
232 VARICOSE VEIN 24 0.0047
233 AFFECTIVE DISORDER 35 0.0045
234 BLOOD UREA INCREASED 75 0.0045
235 FACET JOINT SYNDROME 14 0.0045
236 HYPERLIPIDAEMIA 53 0.0045
237 ATTENTION DEFICIT HYPERACTIVITY DISORDER 18 0.0044
238 MUSCLE TWITCHING 100 0.0044
239 INFUSION SITE HAEMORRHAGE 14 0.0044
240 SPINAL DISORDER 41 0.0044
241 FLANK PAIN 40 0.0043
242 METABOLIC ACIDOSIS 135 0.0043
243 GASTROINTESTINAL TOXICITY 20 0.0043
244 TRICUSPID VALVE INCOMPETENCE 33 0.0042
245 LEFT VENTRICULAR FAILURE 14 0.0042
246 DRUG ERUPTION 72 0.0041
247 CHOLANGITIS 25 0.0041
248 HYPOPNOEA 14 0.0041
249 SENSITIVITY TO WEATHER CHANGE 21 0.0041
250 HIATUS HERNIA 52 0.0041
251 POLYARTHRITIS 21 0.0041
252 JOINT RANGE OF MOTION DECREASED 53 0.0040
253 GLOSSITIS 14 0.0040
254 SKIN ULCER 101 0.0040
255 BRONCHIECTASIS 26 0.0040
256 TOOTH DISORDER 87 0.0039
257 INCORRECT PRODUCT ADMINISTRATION DURATION 78 0.0039
258 FOETAL GROWTH RESTRICTION 23 0.0039
259 MUSCULAR WEAKNESS 431 0.0038
260 HAEMOGLOBIN INCREASED 17 0.0038
261 RENAL TUBULAR NECROSIS 37 0.0038
262 CARDIAC FAILURE CHRONIC 16 0.0038
263 BUNDLE BRANCH BLOCK LEFT 16 0.0038
264 SEASONAL ALLERGY 52 0.0037
265 SINUS TACHYCARDIA 52 0.0037
266 HYPERHIDROSIS 462 0.0036
267 TRANSIENT ISCHAEMIC ATTACK 121 0.0036
268 VENTRICULAR ARRHYTHMIA 13 0.0036
269 ANGIOPATHY 20 0.0036
270 ENCEPHALITIS 24 0.0035
271 BLOOD PRESSURE SYSTOLIC INCREASED 68 0.0035
272 BURNING SENSATION 243 0.0035
273 COGNITIVE DISORDER 161 0.0035
274 RED BLOOD CELL COUNT DECREASED 99 0.0035
275 DIALYSIS 49 0.0035
276 RASH MACULO-PAPULAR 76 0.0035
277 PROTEIN URINE PRESENT 17 0.0035
278 FACIAL PARALYSIS 29 0.0035
279 SINUSITIS 351 0.0035
280 DEFORMITY 32 0.0035
281 RHEUMATOID ARTHRITIS 386 0.0035
282 TINNITUS 157 0.0035
283 PAIN OF SKIN 92 0.0035
284 PULMONARY FIBROSIS 65 0.0034
285 DYSPHAGIA 321 0.0034
286 PRODUCT ADMINISTRATION INTERRUPTED 26 0.0034
287 IRON DEFICIENCY 15 0.0034
288 HEPATIC CYTOLYSIS 41 0.0034
289 BODY TEMPERATURE DECREASED 33 0.0034
290 DRUG LEVEL INCREASED 55 0.0034
291 IMPAIRED WORK ABILITY 71 0.0034
292 CATARACT 196 0.0033
293 IMPAIRED HEALING 108 0.0033
294 BENIGN PROSTATIC HYPERPLASIA 17 0.0033
295 RHINORRHOEA 211 0.0033
296 MITRAL VALVE INCOMPETENCE 37 0.0033
297 INFUSION SITE ERYTHEMA 27 0.0033
298 ASTHMA 364 0.0033
299 HYPERCALCAEMIA 40 0.0033
300 DRUG INTOLERANCE 311 0.0033
301 DYSPHONIA 188 0.0033
302 SYNOVITIS 58 0.0033
303 DIVERTICULUM INTESTINAL 14 0.0033
304 INJECTION SITE EXTRAVASATION 40 0.0032
305 BASAL CELL CARCINOMA 50 0.0032
306 DERMATITIS BULLOUS 23 0.0032
307 SPINAL OSTEOARTHRITIS 28 0.0032
308 LIP SWELLING 105 0.0032
309 BLOOD PRESSURE FLUCTUATION 76 0.0032
310 GASTROINTESTINAL DISORDER 279 0.0032
311 HYPOALBUMINAEMIA 24 0.0032
312 NOCTURIA 38 0.0032
313 INTERSTITIAL LUNG DISEASE 151 0.0032
314 PHOTOPHOBIA 58 0.0031
315 CONJUNCTIVITIS 57 0.0031
316 EYE PRURITUS 102 0.0031
317 THERAPEUTIC PRODUCT EFFECT DECREASED 137 0.0031
318 EYELID OEDEMA 36 0.0031
319 UPPER-AIRWAY COUGH SYNDROME 25 0.0031
320 HYPERTHERMIA 23 0.0031
321 TOXIC ENCEPHALOPATHY 15 0.0031
322 PLEURISY 18 0.0031
323 NASAL CONGESTION 176 0.0030
324 BLINDNESS 122 0.0030
325 RASH PAPULAR 67 0.0030
326 PHARYNGOLARYNGEAL PAIN 16 0.0030
327 UPPER RESPIRATORY TRACT INFECTION 137 0.0030
328 SKIN PLAQUE 25 0.0030
329 PRESCRIBED UNDERDOSE 59 0.0030
330 PALPITATIONS 346 0.0030
331 IRON DEFICIENCY ANAEMIA 27 0.0030
332 CHOLESTASIS 56 0.0030
333 SUPRAVENTRICULAR TACHYCARDIA 28 0.0030
334 HEPATIC STEATOSIS 54 0.0029
335 BLOOD ALKALINE PHOSPHATASE INCREASED 72 0.0029
336 MUSCULOSKELETAL STIFFNESS 253 0.0029
337 NASAL DRYNESS 18 0.0029
338 HYPERCHLORHYDRIA 17 0.0029
339 SERUM FERRITIN INCREASED 15 0.0029
340 NODULE 37 0.0029
341 HYPERNATRAEMIA 14 0.0029
342 BUNDLE BRANCH BLOCK RIGHT 13 0.0029
343 SWELLING FACE 183 0.0029
344 RENAL FAILURE 376 0.0028
345 RESPIRATORY DISTRESS 77 0.0028
346 LUNG DISORDER 136 0.0028
347 ANKLE FRACTURE 43 0.0028
348 TOXIC SKIN ERUPTION 28 0.0028
349 CARDIAC MURMUR 24 0.0028
350 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 28 0.0028
351 TENDON RUPTURE 34 0.0028
352 APHTHOUS ULCER 21 0.0028
353 SOMNAMBULISM 18 0.0028
354 CARDIAC TAMPONADE 13 0.0028
355 PULMONARY OEDEMA 122 0.0028
356 PROTEINURIA 51 0.0027
357 HYPOCALCAEMIA 51 0.0027
358 ATRIOVENTRICULAR BLOCK COMPLETE 18 0.0027
359 LUNG INFILTRATION 24 0.0027
360 DRY EYE 130 0.0027
361 CARDIOMEGALY 33 0.0027
362 BLOOD ALBUMIN DECREASED 21 0.0027
363 OXYGEN SATURATION DECREASED 148 0.0027
364 CARDIAC DISORDER 244 0.0026
365 MENISCUS INJURY 16 0.0026
366 BRUXISM 14 0.0026
367 CORONARY ARTERY STENOSIS 13 0.0026
368 EOSINOPHILIA 45 0.0026
369 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 43 0.0026
370 MULTIPLE ALLERGIES 20 0.0026
371 HYPERTENSION 536 0.0026
372 GASTRIC ULCER 48 0.0026
373 INTENTIONAL PRODUCT USE ISSUE 220 0.0025
374 DIVERTICULUM 18 0.0025
375 MUSCULOSKELETAL DISCOMFORT 43 0.0025
376 LIPASE INCREASED 19 0.0025
377 LYMPHOCYTE COUNT DECREASED 44 0.0025
378 BLOOD CREATININE INCREASED 162 0.0025
379 INTERVERTEBRAL DISC DEGENERATION 23 0.0025
380 DECREASED IMMUNE RESPONSIVENESS 24 0.0025
381 ACUTE RESPIRATORY FAILURE 47 0.0025
382 HELICOBACTER INFECTION 25 0.0025
383 VITAMIN D DECREASED 21 0.0025
384 CROHN'S DISEASE 17 0.0025
385 RENAL FAILURE ACUTE 105 0.0025
386 COVID-19 PNEUMONIA 29 0.0025
387 ABDOMINAL PAIN UPPER 501 0.0025
388 EOSINOPHIL COUNT INCREASED 20 0.0024
389 INFUSION RELATED REACTION 159 0.0024
390 LIVER DISORDER 106 0.0024
391 AGRANULOCYTOSIS 44 0.0024
392 HAND DEFORMITY 31 0.0024
393 BACTERIAL INFECTION 44 0.0024
394 DRUG-INDUCED LIVER INJURY 73 0.0024
395 MUSCULOSKELETAL PAIN 125 0.0024
396 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 17 0.0024
397 ISCHAEMIC STROKE 42 0.0024
398 C-REACTIVE PROTEIN ABNORMAL 15 0.0024
399 ABDOMINAL DISCOMFORT 389 0.0024
400 THROAT IRRITATION 104 0.0024
401 CONCUSSION 18 0.0024
402 FOLLICULITIS 24 0.0024
403 SKIN LACERATION 25 0.0023
404 SEPTIC SHOCK 100 0.0023
405 HYPOPHOSPHATAEMIA 17 0.0023
406 HYPONATRAEMIA 130 0.0023
407 COUGH 647 0.0023
408 HEPATITIS 59 0.0023
409 FEELING JITTERY 44 0.0023
410 PHARYNGEAL SWELLING 22 0.0023
411 HYPERCHOLESTEROLAEMIA 22 0.0023
412 JAUNDICE 62 0.0023
413 ALANINE AMINOTRANSFERASE INCREASED 141 0.0023
414 EMPHYSEMA 23 0.0023
415 SCIATICA 36 0.0023
416 HALLUCINATION 169 0.0023
417 CONFUSIONAL STATE 365 0.0023
418 HYPOKALAEMIA 103 0.0023
419 RASH PRURITIC 121 0.0023
420 INFLAMMATION 115 0.0023
421 BOWEL MOVEMENT IRREGULARITY 17 0.0023
422 HYPERTRIGLYCERIDAEMIA 13 0.0023
423 PERIPHERAL SENSORY NEUROPATHY 13 0.0023
424 AMNESIA 145 0.0022
425 INJECTION SITE IRRITATION 28 0.0022
426 JOINT STIFFNESS 58 0.0022
427 HYPERSENSITIVITY 409 0.0022
428 GASTRITIS 58 0.0022
429 BRONCHITIS 164 0.0022
430 TYPE 2 DIABETES MELLITUS 74 0.0022
431 OSTEOARTHRITIS 93 0.0022
432 OVARIAN CYST 22 0.0022
433 OSTEOPOROSIS 90 0.0022
434 JOINT DISLOCATION 23 0.0022
435 ACCIDENT 26 0.0022
436 CHOKING SENSATION 12 0.0022
437 HYPERAESTHESIA 18 0.0022
438 DEHYDRATION 289 0.0022
439 DISTURBANCE IN ATTENTION 117 0.0022
440 GAMMA-GLUTAMYLTRANSFERASE INCREASED 48 0.0022
441 HEPATITIS ACUTE 14 0.0022
442 ATRIAL FIBRILLATION 211 0.0022
443 PRODUCTIVE COUGH 102 0.0022
444 DRUG INTERACTION 341 0.0022
445 PLATELET COUNT INCREASED 28 0.0022
446 JOINT SWELLING 258 0.0022
447 NEUROPATHY PERIPHERAL 202 0.0022
448 RESPIRATORY DISORDER 64 0.0022
449 WHITE BLOOD CELL COUNT INCREASED 82 0.0022
450 ATRIAL FLUTTER 17 0.0021
451 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 118 0.0021
452 SPUTUM DISCOLOURED 20 0.0021
453 GENERALISED OEDEMA 26 0.0021
454 INFUSION SITE SWELLING 13 0.0021
455 HEPATOCELLULAR INJURY 30 0.0021
456 LEFT VENTRICULAR DYSFUNCTION 14 0.0021
457 UNRESPONSIVE TO STIMULI 54 0.0021
458 CHEST DISCOMFORT 214 0.0021
459 CYST 26 0.0021
460 MIGRAINE 198 0.0021
461 HEART RATE INCREASED 206 0.0021
462 HAEMOGLOBIN DECREASED 214 0.0021
463 DYSPNOEA EXERTIONAL 78 0.0021
464 POLYURIA 17 0.0021
465 INFLUENZA 232 0.0021
466 HAEMOLYSIS 16 0.0021
467 MUSCULOSKELETAL CHEST PAIN 32 0.0021
468 EYE IRRITATION 115 0.0021
469 PANCREATITIS ACUTE 46 0.0021
470 CARDIAC FAILURE CONGESTIVE 167 0.0021
471 SKIN EXFOLIATION 171 0.0021
472 LOWER RESPIRATORY TRACT INFECTION 93 0.0021
473 DUODENAL ULCER PERFORATION 15 0.0021
474 CHEST PAIN 379 0.0021
475 SUICIDE ATTEMPT 124 0.0021
476 ANXIETY 582 0.0021
477 ASCITES 60 0.0021
478 DYSPEPSIA 200 0.0021
479 HEPATIC ENZYME INCREASED 137 0.0020
480 PAPULE 14 0.0020
481 FUNGAL INFECTION 67 0.0020
482 EYE PAIN 111 0.0020
483 QUALITY OF LIFE DECREASED 27 0.0020
484 BONE MARROW FAILURE 41 0.0020
485 PLEURAL EFFUSION 122 0.0020
486 ELECTROLYTE IMBALANCE 23 0.0020
487 LYMPHOMA 31 0.0020
488 NASOPHARYNGITIS 368 0.0020
489 HEPATIC CIRRHOSIS 37 0.0020
490 CANDIDA INFECTION 33 0.0020
491 INFECTION 285 0.0020
492 INFLUENZA LIKE ILLNESS 163 0.0020
493 SWELLING 184 0.0020
494 HEADACHE 1233 0.0020
495 MUSCLE STRAIN 17 0.0020
496 BACK PAIN 456 0.0020
497 TACHYCARDIA 174 0.0020
498 INFUSION SITE PAIN 25 0.0020
499 DYSURIA 72 0.0020
500 RHABDOMYOLYSIS 81 0.0020
501 IMPAIRED QUALITY OF LIFE 28 0.0020
502 ARTHRALGIA 806 0.0020
503 PNEUMONIA 628 0.0020
504 RENAL IMPAIRMENT 162 0.0020
505 CORONARY ARTERY DISEASE 59 0.0020
506 POSTOPERATIVE WOUND INFECTION 13 0.0020
507 ACUTE RESPIRATORY DISTRESS SYNDROME 34 0.0019
508 HYPERKALAEMIA 67 0.0019
509 ORAL PAIN 43 0.0019
510 OROPHARYNGEAL DISCOMFORT 17 0.0019
511 DRY MOUTH 154 0.0019
512 NEPHROTIC SYNDROME 13 0.0019
513 EYE INFECTION 21 0.0019
514 HEART RATE DECREASED 66 0.0019
515 BLOOD SODIUM DECREASED 35 0.0019
516 TOXIC EPIDERMAL NECROLYSIS 28 0.0019
517 ASPARTATE AMINOTRANSFERASE INCREASED 98 0.0019
518 MYOCLONUS 22 0.0019
519 BLOOD THYROID STIMULATING HORMONE INCREASED 17 0.0019
520 POOR VENOUS ACCESS 19 0.0019
521 BLOOD PRESSURE INCREASED 281 0.0019
522 OESOPHAGITIS 20 0.0019
523 MIDDLE INSOMNIA 34 0.0019
524 MULTIPLE ORGAN DYSFUNCTION SYNDROME 51 0.0019
525 ACUTE MYOCARDIAL INFARCTION 54 0.0018
526 HEPATOMEGALY 18 0.0018
527 HEPATIC ENCEPHALOPATHY 17 0.0018
528 CORONARY ARTERY OCCLUSION 25 0.0018
529 MOUTH ULCERATION 38 0.0018
530 HERPES ZOSTER 104 0.0018
531 ORAL HERPES 35 0.0018
532 FALL 598 0.0018
533 RENAL FAILURE CHRONIC 14 0.0018
534 CARDIAC FAILURE 144 0.0018
535 INTENTIONAL OVERDOSE 114 0.0018
536 GLYCOSYLATED HAEMOGLOBIN INCREASED 45 0.0018
537 DYSPNOEA 1007 0.0018
538 PYREXIA 614 0.0018
539 DRUG EFFECT LESS THAN EXPECTED 25 0.0018
540 HYPOXIA 62 0.0018
541 WEIGHT DECREASED 493 0.0018
542 ANAPHYLACTIC REACTION 97 0.0018
543 PHARYNGITIS 22 0.0018
544 HEART RATE IRREGULAR 40 0.0018
545 GINGIVAL PAIN 14 0.0018
546 OEDEMA PERIPHERAL 215 0.0018
547 RESTLESS LEGS SYNDROME 32 0.0018
548 DRUG HYPERSENSITIVITY 341 0.0018
549 EXOSTOSIS 16 0.0018
550 PNEUMONIA BACTERIAL 16 0.0018
551 WOUND INFECTION 19 0.0018
552 PSORIASIS 228 0.0018
553 MYOCARDIAL ISCHAEMIA 20 0.0018
554 HYDRONEPHROSIS 13 0.0018
555 PYELONEPHRITIS 15 0.0018
556 HYSTERECTOMY 15 0.0018
557 HAEMODYNAMIC INSTABILITY 13 0.0018
558 MYOPATHY 15 0.0018
559 PULMONARY HYPERTENSION 36 0.0017
560 ESCHERICHIA INFECTION 14 0.0017
561 NAUSEA 1349 0.0017
562 INTERNATIONAL NORMALISED RATIO INCREASED 49 0.0017
563 CEREBROVASCULAR ACCIDENT 289 0.0017
564 RESPIRATORY FAILURE 124 0.0017
565 TREATMENT FAILURE 139 0.0017
566 PNEUMONIA ASPIRATION 42 0.0017
567 JOINT INJURY 36 0.0017
568 INSURANCE ISSUE 25 0.0017
569 ERUCTATION 32 0.0017
570 DIARRHOEA 1082 0.0017
571 PELVIC FRACTURE 13 0.0017
572 EJECTION FRACTION DECREASED 26 0.0017
573 SENSATION OF FOREIGN BODY 14 0.0017
574 HEPATOTOXICITY 37 0.0017
575 THERAPEUTIC RESPONSE DECREASED 100 0.0017
576 PRODUCT USE IN UNAPPROVED INDICATION 405 0.0017
577 PSEUDOMONAS INFECTION 14 0.0017
578 HAEMATOCRIT DECREASED 33 0.0017
579 ABDOMINAL PAIN 384 0.0017
580 INJECTION SITE REACTION 113 0.0017
581 GASTROENTERITIS 24 0.0017
582 OSTEOPENIA 25 0.0017
583 NERVE COMPRESSION 15 0.0016
584 URINARY INCONTINENCE 48 0.0016
585 INJECTION SITE INDURATION 21 0.0016
586 HEPATIC FUNCTION ABNORMAL 60 0.0016
587 THERAPY NON-RESPONDER 72 0.0016
588 HAEMOPTYSIS 45 0.0016
589 GRAND MAL CONVULSION 15 0.0016
590 STAPHYLOCOCCAL INFECTION 53 0.0016
591 PNEUMOCYSTIS JIROVECII PNEUMONIA 16 0.0016
592 CHOLECYSTITIS 19 0.0016
593 INTERVERTEBRAL DISC PROTRUSION 35 0.0016
594 BLOOD CALCIUM DECREASED 18 0.0016
595 COVID-19 282 0.0016
596 DELIRIUM 55 0.0016
597 HEPATIC FAILURE 48 0.0016
598 DERMATITIS CONTACT 18 0.0016
599 CHOLECYSTECTOMY 18 0.0016
600 EAR INFECTION 42 0.0016
601 SKIN LESION 43 0.0016
602 BONE DENSITY DECREASED 50 0.0016
603 ARTHROPATHY 88 0.0016
604 RESPIRATORY RATE INCREASED 14 0.0016
605 PSORIATIC ARTHROPATHY 63 0.0016
606 GLOSSODYNIA 35 0.0016
607 PAIN 961 0.0016
608 RIB FRACTURE 32 0.0016
609 HAEMOLYTIC ANAEMIA 14 0.0016
610 DIVERTICULITIS 43 0.0016
611 BRONCHOPULMONARY ASPERGILLOSIS 12 0.0016
612 GASTROINTESTINAL PAIN 17 0.0016
613 ATRIOVENTRICULAR BLOCK 12 0.0016
614 ILEUS 19 0.0016
615 LIVER FUNCTION TEST ABNORMAL 45 0.0016
616 VENTRICULAR EXTRASYSTOLES 16 0.0016
617 NECK PAIN 86 0.0016
618 SUBDURAL HAEMATOMA 22 0.0016
619 ALTERED STATE OF CONSCIOUSNESS 33 0.0016
620 APNOEA 12 0.0016
621 BACTERAEMIA 18 0.0015
622 ASTHENIA 574 0.0015
623 GASTRIC DISORDER 53 0.0015
624 VISUAL IMPAIRMENT 187 0.0015
625 BODY TEMPERATURE INCREASED 31 0.0015
626 INCONTINENCE 16 0.0015
627 BLOOD MAGNESIUM DECREASED 13 0.0015
628 BLOOD LACTATE DEHYDROGENASE INCREASED 24 0.0015
629 RETCHING 32 0.0015
630 MICTURITION URGENCY 17 0.0015
631 INTENTIONAL DOSE OMISSION 41 0.0015
632 HAEMATOMA 39 0.0015
633 IMMUNOSUPPRESSION 13 0.0015
634 ECONOMIC PROBLEM 23 0.0015
635 OROPHARYNGEAL PAIN 138 0.0015
636 TUMOUR LYSIS SYNDROME 13 0.0015
637 LIMB DISCOMFORT 46 0.0015
638 GRIP STRENGTH DECREASED 13 0.0015
639 INTENTIONAL PRODUCT MISUSE 129 0.0015
640 STOMATITIS 90 0.0015
641 PULMONARY MASS 22 0.0015
642 BLOOD PRESSURE DECREASED 98 0.0015
643 INITIAL INSOMNIA 15 0.0015
644 BIPOLAR DISORDER 16 0.0015
645 CONDITION AGGRAVATED 441 0.0015
646 SYNCOPE 146 0.0015
647 HERNIA 28 0.0015
648 DIABETES MELLITUS 111 0.0015
649 URINARY TRACT INFECTION 246 0.0015
650 ELECTROCARDIOGRAM QT PROLONGED 52 0.0015
651 EAR PAIN 28 0.0015
652 MYALGIA 244 0.0015
653 MEMORY IMPAIRMENT 197 0.0015
654 WHITE BLOOD CELL COUNT DECREASED 155 0.0014
655 LEUKOPENIA 71 0.0014
656 GENERAL PHYSICAL HEALTH DETERIORATION 163 0.0014
657 DISSEMINATED INTRAVASCULAR COAGULATION 20 0.0014
658 HAEMATEMESIS 36 0.0014
659 ANAEMIA 270 0.0014
660 SYSTEMIC LUPUS ERYTHEMATOSUS 50 0.0014
661 OCULAR HYPERAEMIA 66 0.0014
662 PAIN IN JAW 40 0.0014
663 HYPOAESTHESIA 211 0.0014
664 DEPRESSED MOOD 74 0.0014
665 LACTIC ACIDOSIS 45 0.0014
666 HYPOTENSION 278 0.0014
667 RESPIRATORY TRACT INFECTION 36 0.0014
668 FATIGUE 1075 0.0014
669 HALLUCINATION, VISUAL 29 0.0014
670 PANCYTOPENIA 77 0.0014
671 GASTROENTERITIS VIRAL 25 0.0014
672 PAIN IN EXTREMITY 407 0.0014
673 OBESITY 22 0.0014
674 ARTERIOSCLEROSIS 13 0.0014
675 IMMUNE SYSTEM DISORDER 18 0.0014
676 WOUND 38 0.0014
677 BLOOD BILIRUBIN INCREASED 37 0.0014
678 BLOOD PRESSURE ABNORMAL 27 0.0014
679 STRESS 98 0.0014
680 INTESTINAL OBSTRUCTION 51 0.0014
681 SHOCK 31 0.0014
682 NEUTROPHIL COUNT DECREASED 55 0.0014
683 FACE OEDEMA 23 0.0014
684 FEELING ABNORMAL 324 0.0014
685 WEIGHT FLUCTUATION 14 0.0014
686 DRY SKIN 176 0.0014
687 INTESTINAL PERFORATION 15 0.0014
688 ROTATOR CUFF SYNDROME 17 0.0013
689 BRADYCARDIA 70 0.0013
690 BLOOD GLUCOSE INCREASED 249 0.0013
691 FOOT FRACTURE 25 0.0013
692 MELAENA 29 0.0013
693 HAEMATURIA 45 0.0013
694 BLOOD CHOLESTEROL INCREASED 61 0.0013
695 ORAL CANDIDIASIS 17 0.0013
696 SMALL INTESTINAL OBSTRUCTION 16 0.0013
697 DRUG TOXICITY 18 0.0013
698 DISCOMFORT 79 0.0013
699 RECTAL HAEMORRHAGE 56 0.0013
700 RASH 563 0.0013
701 INSOMNIA 346 0.0013
702 BLOOD POTASSIUM INCREASED 21 0.0013
703 APHONIA 18 0.0013
704 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 67 0.0013
705 COMA 61 0.0013
706 NIGHT SWEATS 41 0.0013
707 PRODUCT USE ISSUE 238 0.0013
708 SEPSIS 142 0.0013
709 FLATULENCE 72 0.0013
710 HEAD INJURY 40 0.0013
711 ROAD TRAFFIC ACCIDENT 53 0.0013
712 BLOOD GLUCOSE DECREASED 61 0.0013
713 BLOOD CREATINE PHOSPHOKINASE INCREASED 37 0.0013
714 HYPOPHAGIA 32 0.0013
715 DEAFNESS 33 0.0013
716 PNEUMONITIS 34 0.0013
717 STEVENS-JOHNSON SYNDROME 28 0.0013
718 OEDEMA 68 0.0013
719 CYTOPENIA 15 0.0013
720 IMPAIRED GASTRIC EMPTYING 16 0.0013
721 FEEDING DISORDER 25 0.0013
722 VERTIGO 76 0.0013
723 UPPER GASTROINTESTINAL HAEMORRHAGE 21 0.0013
724 ALOPECIA 244 0.0013
725 THROMBOSIS 100 0.0013
726 ADVERSE EVENT 114 0.0013
727 DISEASE RECURRENCE 59 0.0013
728 BALANCE DISORDER 107 0.0013
729 DEPRESSION 282 0.0013
730 SKIN DISORDER 41 0.0012
731 SLEEP DISORDER 86 0.0012
732 CEREBRAL INFARCTION 30 0.0012
733 PULMONARY EMBOLISM 117 0.0012
734 BACK DISORDER 20 0.0012
735 CHOLELITHIASIS 40 0.0012
736 THROMBOCYTOPENIA 136 0.0012
737 SUDDEN DEATH 13 0.0012
738 INJECTION SITE WARMTH 25 0.0012
739 LYMPHADENOPATHY 43 0.0012
740 ECZEMA 61 0.0012
741 DEEP VEIN THROMBOSIS 79 0.0012
742 DISORIENTATION 48 0.0012
743 FEELING HOT 74 0.0012
744 FLUSHING 123 0.0012
745 SPINAL FRACTURE 24 0.0012
746 BODY HEIGHT DECREASED 13 0.0012
747 CHILLS 141 0.0012
748 BACK INJURY 13 0.0012
749 OCULAR DISCOMFORT 13 0.0012
750 FEBRILE NEUTROPENIA 79 0.0012
751 BRONCHOSPASM 17 0.0012
752 BLOOD TRIGLYCERIDES INCREASED 21 0.0012
753 PLATELET COUNT DECREASED 126 0.0012
754 DIZZINESS 586 0.0012
755 POLYNEUROPATHY 14 0.0012
756 ACUTE HEPATIC FAILURE 16 0.0012
757 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 30 0.0012
758 GOUT 21 0.0012
759 NEPHROPATHY TOXIC 13 0.0012
760 SKIN INFECTION 13 0.0012
761 DELUSION 18 0.0012
762 PRESYNCOPE 28 0.0012
763 PARAESTHESIA 182 0.0012
764 STATUS EPILEPTICUS 13 0.0012
765 OFF LABEL USE 994 0.0012
766 IMPAIRED DRIVING ABILITY 13 0.0012
767 ERYTHEMA 234 0.0012
768 ABDOMINAL DISTENSION 118 0.0012
769 BLOOD POTASSIUM DECREASED 34 0.0011
770 CLOSTRIDIUM DIFFICILE COLITIS 12 0.0011
771 HOSPITALISATION 172 0.0011
772 TOOTH EXTRACTION 14 0.0011
773 IRRITABLE BOWEL SYNDROME 24 0.0011
774 POOR QUALITY SLEEP 24 0.0011
775 FLUID RETENTION 57 0.0011
776 COLITIS 42 0.0011
777 ILLNESS 112 0.0011
778 NEURALGIA 27 0.0011
779 VIRAL INFECTION 37 0.0011
780 DISABILITY 22 0.0011
781 THROAT TIGHTNESS 30 0.0011
782 SPLENOMEGALY 13 0.0011
783 CELLULITIS 56 0.0011
784 FAECES DISCOLOURED 24 0.0011
785 LEUKOCYTOSIS 20 0.0011
786 TASTE DISORDER 22 0.0011
787 ANHEDONIA 29 0.0011
788 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 193 0.0011
789 GLAUCOMA 21 0.0011
790 BONE DISORDER 20 0.0011
791 WEIGHT INCREASED 242 0.0011
792 CYTOMEGALOVIRUS INFECTION 18 0.0011
793 URINARY RETENTION 36 0.0011
794 TRANSAMINASES INCREASED 24 0.0011
795 HEAD DISCOMFORT 19 0.0011
796 DRUG INEFFECTIVE 1418 0.0011
797 COLITIS ULCERATIVE 48 0.0011
798 GLOMERULAR FILTRATION RATE DECREASED 13 0.0011
799 PNEUMOTHORAX 17 0.0011
800 ANOREXIA 14 0.0011
801 DYSGEUSIA 80 0.0011
802 URTICARIA 178 0.0011
803 RASH ERYTHEMATOUS 50 0.0011
804 SKIN DISCOLOURATION 49 0.0011
805 CONSTIPATION 230 0.0011
806 RASH MACULAR 37 0.0011
807 CLOSTRIDIUM DIFFICILE INFECTION 23 0.0011
808 HOT FLUSH 80 0.0011
809 MULTIPLE SCLEROSIS 51 0.0011
810 SKIN FISSURES 20 0.0011
811 POLLAKIURIA 44 0.0011
812 LOSS OF CONSCIOUSNESS 135 0.0011
813 SURGERY 61 0.0011
814 MYOCARDIAL INFARCTION 185 0.0011
815 PANIC ATTACK 38 0.0011
816 PRODUCT TASTE ABNORMAL 14 0.0011
817 THERAPEUTIC RESPONSE SHORTENED 33 0.0011
818 LIMB INJURY 28 0.0010
819 LIVER INJURY 25 0.0010
820 TACHYPNOEA 14 0.0010
821 HYPOGLYCAEMIA 50 0.0010
822 HIP FRACTURE 33 0.0010
823 PRODUCT DOSE OMISSION ISSUE 292 0.0010
824 MULTI-ORGAN FAILURE 18 0.0010
825 NEOPLASM PROGRESSION 36 0.0010
826 ENCEPHALOPATHY 25 0.0010
827 VISION BLURRED 139 0.0010
828 EPILEPSY 31 0.0010
829 GASTRIC CANCER 26 0.0010
830 ANAPHYLACTIC SHOCK 26 0.0010
831 NEEDLE ISSUE 29 0.0010
832 THIRST 18 0.0010
833 INCORRECT DOSE ADMINISTERED 225 0.0010
834 ANKYLOSING SPONDYLITIS 13 0.0010
835 DECREASED APPETITE 231 0.0010
836 CYTOKINE RELEASE SYNDROME 19 0.0010
837 BLOOD URINE PRESENT 19 0.0010
838 HYPOAESTHESIA ORAL 15 0.0010
839 THERAPY PARTIAL RESPONDER 15 0.0010
840 MOBILITY DECREASED 71 0.0010
841 MUSCLE TIGHTNESS 16 0.0010
842 POST PROCEDURAL COMPLICATION 19 0.0010
843 HAEMATOCHEZIA 54 0.0010
844 CONTUSION 94 0.0010
845 DEMENTIA 27 0.0010
846 HYPERTHYROIDISM 14 0.0010
847 PANCREATITIS 51 0.0010
848 MUCOSAL INFLAMMATION 25 0.0010
849 LUNG INFECTION 15 0.0010
850 MUSCLE SPASMS 173 0.0010
851 LIVER FUNCTION TEST INCREASED 20 0.0010
852 DEVICE OCCLUSION 13 0.0009
853 FEMUR FRACTURE 29 0.0009
854 CHOKING 18 0.0009
855 PRURITUS GENERALISED 20 0.0009
856 CARDIOGENIC SHOCK 13 0.0009
857 LOCALISED INFECTION 22 0.0009
858 HYPERGLYCAEMIA 33 0.0009
859 ABDOMINAL PAIN LOWER 23 0.0009
860 PARAESTHESIA ORAL 13 0.0009
861 FULL BLOOD COUNT DECREASED 18 0.0009
862 SOMNOLENCE 179 0.0009
863 INJECTION SITE HAEMATOMA 13 0.0009
864 CHROMATURIA 20 0.0009
865 EXPOSURE VIA SKIN CONTACT 20 0.0009
866 IMMUNODEFICIENCY 13 0.0009
867 OSTEONECROSIS 29 0.0009
868 HAEMORRHOIDS 17 0.0009
869 NEOPLASM MALIGNANT 58 0.0009
870 DERMATITIS 18 0.0009
871 BLOOD GLUCOSE ABNORMAL 16 0.0009
872 ABNORMAL DREAMS 24 0.0009
873 ORTHOSTATIC HYPOTENSION 15 0.0009
874 AGITATION 63 0.0009
875 METASTASES TO LIVER 15 0.0009
876 FREQUENT BOWEL MOVEMENTS 23 0.0009
877 LETHARGY 49 0.0009
878 MANIA 14 0.0009
879 INCREASED APPETITE 16 0.0009
880 GAIT INABILITY 28 0.0009
881 FRACTURE 16 0.0009
882 DEVICE RELATED INFECTION 13 0.0009
883 LACRIMATION INCREASED 25 0.0008
884 DEPRESSED LEVEL OF CONSCIOUSNESS 33 0.0008
885 CARDIAC ARREST 69 0.0008
886 GASTROINTESTINAL HAEMORRHAGE 70 0.0008
887 PERITONITIS 17 0.0008
888 ARRHYTHMIA 39 0.0008
889 FEAR 22 0.0008
890 SENSORY DISTURBANCE 13 0.0008
891 MOVEMENT DISORDER 26 0.0008
892 EPISTAXIS 60 0.0008
893 UPPER LIMB FRACTURE 16 0.0008
894 TREMOR 132 0.0008
895 NEUTROPENIA 106 0.0008
896 ADVERSE DRUG REACTION 69 0.0008
897 GAIT DISTURBANCE 148 0.0008
898 PALLOR 21 0.0008
899 PELVIC PAIN 14 0.0008
900 BONE PAIN 45 0.0008
901 PRODUCT SUBSTITUTION ISSUE 44 0.0008
902 CIRCULATORY COLLAPSE 13 0.0008
903 CONVULSION 44 0.0008
904 PRODUCT AVAILABILITY ISSUE 17 0.0008
905 MEDICATION ERROR 42 0.0008
906 MENTAL STATUS CHANGES 21 0.0008
907 RESTLESSNESS 27 0.0007
908 HYPERSOMNIA 21 0.0007
909 WRONG TECHNIQUE IN DRUG USAGE PROCESS 27 0.0007
910 INJECTION SITE MASS 27 0.0007
911 BLISTER 41 0.0007
912 EYE SWELLING 27 0.0007
913 ILL-DEFINED DISORDER 44 0.0007
914 DYSSTASIA 21 0.0007
915 CARDIO-RESPIRATORY ARREST 30 0.0007
916 PRODUCT DOSE OMISSION IN ERROR 19 0.0007
917 SPEECH DISORDER 37 0.0007
918 THINKING ABNORMAL 13 0.0007
919 LOWER LIMB FRACTURE 13 0.0007
920 KNEE ARTHROPLASTY 14 0.0007
921 OVERDOSE 145 0.0007
922 TREATMENT NONCOMPLIANCE 36 0.0007
923 MOOD ALTERED 18 0.0007
924 INJECTION SITE PRURITUS 44 0.0007
925 ERECTILE DYSFUNCTION 17 0.0007
926 MYELOSUPPRESSION 22 0.0007
927 DERMATITIS ATOPIC 32 0.0006
928 PSYCHOTIC DISORDER 18 0.0006
929 FEELING COLD 17 0.0006
930 NERVOUSNESS 32 0.0006
931 INJECTION SITE PAIN 183 0.0006
932 MENTAL DISORDER 26 0.0006
933 INJECTION SITE RASH 18 0.0006
934 MATERNAL EXPOSURE DURING PREGNANCY 51 0.0006
935 SUICIDAL IDEATION 52 0.0006
936 HAEMORRHAGE 59 0.0006
937 EYE DISORDER 18 0.0006
938 PROCEDURAL PAIN 15 0.0005
939 MALIGNANT NEOPLASM PROGRESSION 55 0.0005
940 INJECTION SITE URTICARIA 13 0.0005
941 HYPOACUSIS 23 0.0005
942 INJECTION SITE ERYTHEMA 66 0.0005
943 UNDERDOSE 39 0.0005
944 PRODUCT DOSE OMISSION 35 0.0005
945 INCORRECT DRUG ADMINISTRATION DURATION 15 0.0005
946 TOXICITY TO VARIOUS AGENTS 87 0.0005
947 DRUG EFFECT INCOMPLETE 19 0.0005
948 CEREBRAL HAEMORRHAGE 18 0.0005
949 EXPOSURE DURING PREGNANCY 31 0.0005
950 RASH GENERALISED 13 0.0005
951 DYSKINESIA 20 0.0005
952 SKIN BURNING SENSATION 35 0.0005
953 UNEVALUABLE EVENT 37 0.0005
954 INJECTION SITE SWELLING 37 0.0005
955 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 96 0.0005
956 BREAST CANCER 44 0.0005
957 THERAPY INTERRUPTED 32 0.0005
958 PLASMA CELL MYELOMA 18 0.0005
959 LUNG NEOPLASM MALIGNANT 19 0.0005
960 INJECTION SITE BRUISING 36 0.0005
961 DISEASE PROGRESSION 53 0.0005
962 NERVOUS SYSTEM DISORDER 14 0.0005
963 THERAPEUTIC RESPONSE UNEXPECTED 20 0.0005
964 ABNORMAL BEHAVIOUR 17 0.0004
965 EXTRA DOSE ADMINISTERED 17 0.0004
966 AGGRESSION 21 0.0004
967 MOOD SWINGS 13 0.0004
968 FOETAL EXPOSURE DURING PREGNANCY 32 0.0004
969 VISUAL ACUITY REDUCED 13 0.0004
970 EMOTIONAL DISTRESS 47 0.0004
971 SEIZURE 44 0.0004
972 ANGER 13 0.0004
973 COMPLETED SUICIDE 32 0.0004
974 DEATH 321 0.0004
975 CRYING 13 0.0004
976 INJECTION SITE HAEMORRHAGE 28 0.0004
977 DEVICE ISSUE 29 0.0003
978 INJURY 23 0.0003
979 MULTIPLE SCLEROSIS RELAPSE 21 0.0003
980 IRRITABILITY 18 0.0003
981 DRUG ABUSE 24 0.0003
982 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 20 0.0003
983 DRUG DOSE OMISSION 43 0.0003
984 DRUG EFFECT DECREASED 14 0.0003
985 ACNE 19 0.0003
986 DEVICE MALFUNCTION 16 0.0002
987 PRODUCT QUALITY ISSUE 32 0.0002
988 NO ADVERSE EVENT 37 0.0002
989 DRUG WITHDRAWAL SYNDROME 14 0.0002
990 ACCIDENTAL EXPOSURE TO PRODUCT 15 0.0002
991 DRUG DEPENDENCE 21 0.0001